Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 63.70%
March 31, 2026 63.90%
December 31, 2025 66.67%
September 30, 2025 64.91%
June 30, 2025 63.41%
March 31, 2025 63.12%
December 31, 2024 62.94%
September 30, 2024 61.79%
June 30, 2024 58.83%
March 31, 2024 56.72%
December 31, 2023 51.38%
September 30, 2023 45.10%
June 30, 2023 45.24%
March 31, 2023 38.73%
December 31, 2022 41.41%
September 30, 2022 44.69%
June 30, 2022 44.89%
March 31, 2022 46.83%
December 31, 2021 45.60%
September 30, 2021 48.54%
June 30, 2021 46.41%
March 31, 2021 56.14%
December 31, 2020 46.71%
September 30, 2020 47.20%
June 30, 2020 45.72%
Date Value
March 31, 2020 52.16%
December 31, 2019 46.59%
September 30, 2019 43.68%
June 30, 2019 41.06%
March 31, 2019 35.20%
December 31, 2018 36.10%
September 30, 2018 36.15%
June 30, 2018 35.00%
March 31, 2018 34.89%
December 31, 2017 29.44%
September 30, 2017 38.09%
June 30, 2017 33.90%
March 31, 2017 31.76%
December 31, 2016 22.92%
September 30, 2016 36.42%
June 30, 2016 40.42%
March 31, 2016 47.76%
December 31, 2015 40.65%
September 30, 2015 33.54%
June 30, 2015 44.38%
March 31, 2015 47.63%
September 30, 2014 55.01%
June 30, 2014 46.94%
March 31, 2014 41.75%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Guardant Health, Inc. 65.39%
Myriad Genetics, Inc. 62.51%
CareDx, Inc. 73.37%
Caris Life Sciences, Inc. 68.10%
BioRestorative Therapies, Inc. -157.8%

Gross Profit Margin (Quarterly) Related Metrics